Barry Duplantis

UVic spin-off company DuVax —whose patented technology will be used to create bacterial vaccines—is the winner of the 2010 BCIC Emerging Technology Award (www.bcic.ca). UVic PhD student Barry Duplantis founded Duvax earlier this year with his father. The $25,000 award recognizes a pre-investment venture that has developed a new technology with strong potential for global commercialization. "This award will allow us to further the commercialization potential of our technology and give us an upper hand in competing in the global business environment," he says.